Infectious diseases caused by bacterial, viral or parasitic pathogens are a major burden to global health. PerkinElmer's imaging and high-content analysis solutions play a vital role in infectious disease research such as enabling high-throughput functional and phenotypic assays that can be adapted to a wide range of pathogens.
SARS-CoV-2 Infection & Countermeasure Development
Prof. Yoshihiro Kawaoka, a world-renowned virologist from the University of Tokyo, and his colleagues found that SARS-CoV-2 replicates efficiently in the lungs of Syrian hamsters. Learn how the research team showed that Syrian hamsters, along with microCT imaging using the PerkinElmer Quantum system, is a useful model to understand SARS-CoV-2 pathogenesis in the lungs, as well as aid in the development of vaccines and antiviral drugs.
Imaging Oncolytic Virus Infection in Cancer Cells
Oncolytic viruses are genetically modified viruses capable of delivering therapeutic gene payload to cancer cells. This application note highlights using Sindbis pseudovirus genetically modified with firefly luciferase reporter gene to non-invasively evaluate, monitor, and quantify oncolytic viral infection in living tumors and subsequent virus-host interactions in real-time using IVIS® optical imaging.
High-Content Screening: Powerful Novel Antivirals Detection Tool
High-content screening (HCS) has played a significant role in infectious disease research and drug discovery to date and can be a strong tool in the age of COVID-19 and beyond. With a focus on viral diseases, this article will describe how HCS has been used by laboratories around the world to help with three key interventional strategies: drug repurposing to fast track a previously-approved drug to treat new diseases; development of new therapeutics; and vaccine development.
Live Webinar: Virology Workflow Solutions with PerkinElmer
DATE: Wednesday August 19
TIME: 11:30 AST | 12:30 GST
DURATION: 1 hour
Join us for a live webinar on Wednesday, August 19th to learn about how PerkinElmer's solutions meet the needs of many applications for infectious disease detection and research across your workflow.
Gulf Scientific Corporation (GSC) is a leading provider of complete laboratory solutions in the fields of analytical, life and material sciences. Founded in 1990, GSC is headquartered in Dubai, United Arab Emirates, with regional offices and supply chain distribution centers across the Middle East.